Association of time to second-line (2L) immune-checkpoint inhibitors (ICI) and outcomes with ICIs in patients (pts) with advanced urothelial carcinoma (aUC).Dimitrios Makrakis,Rafee Talukder,Scott Dawsey,Lucia Carril,Tyler F. Stewart,Rafael Morales-Barrera,Joseph J. Park,Claudia Angela Maria Fulgenzi,Jure Murgic,Naomi Vather-Wu,Ivan de Kouchkovsky,Michael Edward Devitt,Giuseppe Di Lorenzo,Kavita Gupta,Nishita Tripathi,Roubini Zakopoulou,Abhishek Tripathi,Eric Lu,Petros Grivas,Ali Raza KhakiJOURNAL OF CLINICAL ONCOLOGY（2022）引用 1|浏览12暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
